Anzeige
Mehr »
Freitag, 26.09.2025 - Börsentäglich über 12.000 News
Geheime Börsenchance: Ist das die bedeutendste Kupferentdeckung Kanadas?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PA3U | ISIN: CA58410Q2036 | Ticker-Symbol: P731
Frankfurt
25.09.25 | 08:01
1,770 Euro
+2,31 % +0,040
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDEXUS PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
MEDEXUS PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur MEDEXUS PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoMedexus Pharmaceuticals Inc.: Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors253Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - September 25, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today held its virtual annual meeting of shareholders. Medexus shareholders...
► Artikel lesen
MEDEXUS PHARMACEUTICALS Aktie jetzt für 0€ handeln
15.08.Leede trims price target on Medexus Pharmaceuticals3
13.08.Medexus Pharmaceuticals reports Q1 results1
13.08.Medexus Pharmaceuticals: Umsatzrückgang im Q1 2026 bei positivem Aktientrend1
12.08.Medexus Pharmaceuticals Inc.: Medexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX (treosulfan) for Injection472Fiscal Q1 2026 net revenue of $24.6 million, net income of $0.5 million, operating income of $0.9 million, and Adjusted EBITDA* of $3.4 million$3.0 million of product-level net revenue from GRAFAPEX...
► Artikel lesen
05.08.Medexus Pharmaceuticals Inc: Medexus's Grafapex add-on payment okayed by Medicare2
05.08.Medexus Pharmaceuticals Inc.: Medexus Schedules First Fiscal Quarter 2026 Conference Call476Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 5, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Wednesday, August...
► Artikel lesen
05.08.Medexus Pharmaceuticals Inc.: GRAFAPEX (treosulfan) for Injection Receives CMS Approval of New Technology Add-On Payment (NTAP) for Eligible Cases in CMS's Fiscal Year 2026150Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 5, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that the US Centers for Medicare & Medicaid Services...
► Artikel lesen
26.06.Medexus Pharmaceuticals is a buy, Research Capital says5
26.06.Medexus Pharmaceuticals Inc.: Medexus Announces Strong Fiscal Year 2025 Results, Including Initial Results from Launch of GRAFAPEX (treosulfan) for Injection in the United States505Fiscal year 2025 revenue of $108.3 million, record net income of $2.2 million, operating income of $8.2 million, and record Adjusted EBITDA* of $20.2 millionUS commercial launch of GRAFAPEX executed...
► Artikel lesen
18.06.Medexus Pharmaceuticals Inc: Medexus to file fiscal 2025 results June 251
17.06.Medexus Pharmaceuticals Inc.: Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2025 Conference Call403Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - June 17, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, June...
► Artikel lesen
17.04.Medexus Pharmaceuticals Inc: Medexus completes listing agreement for Trecondyv1
17.04.Stocks in Play: Medexus Pharmaceuticals-
17.04.Medexus Pharmaceuticals Inc.: Medexus Successfully Completes Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in Quebec, Canada532Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 17, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed a listing agreement with the provincial government of...
► Artikel lesen
08.04.Medexus is a "Strong Buy", Raymond James says1
07.04.Medexus Pharmaceuticals Inc: Medexus talks up market response to Grafapex1
07.04.Stocks in Play: Medexus Pharmaceuticals-
07.04.Medexus Pharmaceuticals Inc.: Medexus Provides Update on Progress of Commercialization of GRAFAPEX (treosulfan) for Injection274Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 7, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to provide a business update on the progress of the commercial...
► Artikel lesen
14.03.Medexus Pharmaceuticals Inc.: Medexus Completes Agreement to Return US Commercialization Rights for Gleolan to NX Development Corp.325Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 14, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed an agreement with NX Development Corp., the licensor...
► Artikel lesen
Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1